Aspirin May Treat Cancer — But There’s Not Enough Money In It

By | May 20, 2014
WE believe that it might be possible to treat breast cancer — the leading cause of female cancer death — with a drug that can already be found in nearly every medicine cabinet in the world: Aspirin.

In 2010, we published an observational study in The Journal of Clinical Oncology showing that women with breast cancer who took aspirin at least once a week for various reasons were 50 percent less likely to die of breast cancer. In 2012, British researchers, by combining results from clinical trials that looked at using aspirin to prevent heart disease, found that aspirin was also associated with a significantly lower risk of breast cancer death.

And yet, until now, there have been no randomized trials (the gold standard of research) of aspirin use among women with breast cancer.

It’s not hard to see why: Clinical trials are typically conducted on drugs developed by labs seeking huge profits. No one stands to make money off aspirin, which has been a generic drug since the Treaty of Versailles in 1919, and which costs less than $6 for a year’s supply.

Thankfully, the first randomized clinical trial is now going on in Britain, made possible by funding from a nonprofit group, Cancer Research UK. But the British study is looking at four cancers, and won’t be done until 2025. If we in the United States had funding to do a similar trial, we could combine our data and get answers much faster. If the United States is to maintain its role as the global leader in biomedical research, it must fund its own trial of aspirin in breast cancer.

Aspirin was originally derived from willow bark, which has been used as a painkiller since the time of Hippocrates. We don’t know exactly why it appears to work in fighting cancer. Aspirin reduces inflammation, and that may play a role in inhibiting the growth of tumors — perhaps by slowing the development of new blood vessels that nourish them, or by fighting old cells that keep growing when they should be dying off. It may also inhibitestrogen production, and we know that estrogen fuels the growth of most (but not all) breast cancers.

Continue reading the main story: Source NY TIMES

5 thoughts on “Aspirin May Treat Cancer — But There’s Not Enough Money In It

  1. Ken Roberts

    Instead we stand poised to waste a trillion bucks on climate change . if we put that kind of money into cancer research we would have an answer maybe after the money was spent . The UK seems to be wising up a bunch lately what with now not believing the UN when it comes to the falsehoods and lies concerning the weather.

    Reply
  2. Jean Leclair

    Aspirin, why would you take it when it would cause bleeding to your stomach and other problems. There is an alternate way to help different kind of cancers. Such as taking vitamins and supplements. but you must remember to read about them and how they work. I know, I was diagnosis with colon cancer a little over 5 years ago and had part of my colon taking out. I have been on supplements that get through a reputable seller, watch what I eat, exercise, keep my mind going and pray. Also keep up with healthy sites.

    Reply
  3. Deanna Baugh

    I read a medical report years ago that all cancer begins with an inflammation…or infection…it stands to reason that this information sure could be true! Just take it with food, your stomach would be fine! When I read this report, I was involved in a medical class and had excess to good medical documents.

    Reply
  4. Irene

    Finding a cancer breast cure is a no no because there is too much at stake for all researchers in this field who would lose their jobs. I believe that there is a cure out there for cancer but those who know the answer were shut up. That is my take on some research in other cures for other types of cancer too or sicknesses out there.
    Money is the root of all evil!!!???

    Reply

Leave a Reply to Jean Leclair Cancel reply

Your email address will not be published. Required fields are marked *